Ra Capital Management, L.P. - Jul 26, 2022 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
10%+ Owner
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Stock symbol
ANTX
Transactions as of
Jul 26, 2022
Transactions value $
$180,675
Form type
4
Date filed
7/28/2022, 05:16 PM
Previous filing
Jul 6, 2022
Next filing
Aug 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Purchase $115K +14.9K +0.4% $7.71 3.76M Jul 26, 2022 See footnotes F1, F2, F5
transaction ANTX Common Stock Purchase $65.5K +8.28K +0.22% $7.91 3.77M Jul 27, 2022 See footnotes F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities include 3,347,715 shares held directly by RA Capital Healthcare Fund, L.P. (the "Fund") and 415,612 shares held by RA Capital Nexus Fund II, L.P. (the "Nexus Fund II").
F2 This transaction was executed in multiple trades at prices ranging from $7.43 to $7.92; the price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions, and all other transactions reported in this Form 4, were effected upon request to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3 These securities include 3,355,996 shares held directly by the Fund and 415,612 shares held by the Nexus Fund II.
F4 This transaction was executed in multiple trades at prices ranging from $7.67 to $8.00; the price reported above reflects the weighted average purchase price.
F5 RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and the Nexus Fund II. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.